Robert Renninger, VP of Finance at Athira Pharma, Inc. (ATHA), sold 2,881 shares at $0.56 ($2K) on 2025-01-02, disclosed to the SEC on 2025-01-03.
Open-market sale of $2k ATHA by VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATHA | SELL | 2025-07-02 | $840 | — | Filing → |